
("
AGM Trading Update
The Group is pleased to report that the strong momentum experienced in FY 2024, which delivered significant financial and operational progress, has continued into FY 2025. The Group has delivered a 6.2%* increase in gross profit for the first four months of 2025 compared to the prior year, driven by a year-on-year uplift in temporary worker hours in Recruitment GB, up 6.6% over the same period, reflecting the sustained demand for both temporary and agency recruitment solutions. This excellent performance has been followed by the announcement on
The Board remains focused on capitalising on the Group's strong trading cash flows, repurchasing 15.5 million ordinary shares, at an average price of
The Board is therefore confident that trading across FY 2025 is on track to deliver results in line with recently revised management expectations, as the Group's scale and reputation for service excellence continues to deliver further market share gains.
*Relating to continuing activities
For further information, please contact:
|
via |
|
|
Panmure Liberum (Nominated Adviser and Broker) |
020 3100 2222 |
|
|
Zeus (Joint Broker) |
020 3829 5000 |
|
|
|
020 7390 0230
|
About
Enabling the Future of Work™
Recruitment GB
The Recruitment GB business is a leading provider of flexible blue-collar workers, supplying up to c.35,000 staff per day on average from around 400 sites, across a wide range of industries including supermarkets, drinks, driving, food processing, logistics and manufacturing.
Recruitment
The Recruitment Ireland business is a leading end to end solutions provider operating across multiple industries, ten branch locations and ten onsite customer locations, supplying c.4,500 staff per day on average, and offering RPO, MSP, temporary and permanent solutions across public and private sectors throughout the island of
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the